Positron emission tomography/computed tomography with 18fluoro- deoxyglucose in the detection of local recurrence and distant metastases of pediatric sarcoma

Pediatric Blood and Cancer

Volumn 49, Issue 7, 2007, Pages 901-905

  Weyl Ben Arush, M ^a,d   Israel, O ^b,d   Postovsky, S ^a,d   Militianu, D ^c   Meller, I ^e   Zaidman, I ^a   Even Sapir, A ^e   Bar Shalom, R ^b,d  

^a MEYER CHILDREN S HOSPITAL   (Israel)

^b Technion Israel Institute of Technology ^*  (Israel)

^c Musculoskeletal Unit   (Israel)

^d TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^e TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

Children; Fluoro deoxyglucose; PET CT; Sarcomas

Indexed keywords

FLUORODEOXYGLUCOSE F 18; MEDRONATE TECHNETIUM TC 99M;

ADOLESCENT; ADULT; ARTICLE; BONE SCINTISCANNING; CANCER PATIENT; CANCER RECURRENCE; CANCER RELAPSE; CANCER STAGING; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; EWING SARCOMA; FEMALE; FOLLOW UP; HUMAN; METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOSARCOMA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RHABDOMYOSARCOMA; SARCOMA; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; ADULT; BONE NEOPLASMS; CHILD; CHILD, PRESCHOOL; FEMALE; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; RECURRENCE; RETROSPECTIVE STUDIES; SARCOMA; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 35649001321     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.21150     Document Type: Article

References (14)

1. Korholz D, Verheyen J, Engelbrecht V, et al. Follow-up of patients with osteosarcoma and Ewing's sarcoma: A retrospective cost-benefit analysis. Klin Padiatr 2000;212:220-223 [in German].
2. Reuther G, Mutschler W. Detection of local recurrent disease in musculoskeletal tumors: Magnetic resonance imaging versus computed tomography. Skeletal Radiol 1990;19:85-90.
3. Schulte M, Brecht-Krauss D, Heymer B, et al. Grading of tumors and tumor like lesions of bone: Evaluation by FDG PET. J Nucl Med 2000;41:1695-1701.
4. Schuetze SM, Rubin BP, Vernon C, et al. Use of positron emission tomography in localized extremity soft tissue sarcoma treated with neoadjuvant chemotherapy. Cancer 2005;103:339-348.
5. Franzius C, Daldrup-Link HE, Wagner-Bohn A, et al. FDG-PET for detection of recurrences from malignant primary bone tumors: Comparison with conventional imaging. Ann Oncol 2002;13:157-160.
6. Johnson GR, Zhuang H, Khan J, et al. Role of positron emission tomography with fluorine-18-deoxyglucose in the detection of local recurrent and distant metastatic sarcoma. Clin Nucl Med 2003;28:815-820.
7. Weyl Ben Arush M, Israel O, Kedar Z, et al. Detection of isolated distant metastasis in soft tissue sarcoma by fluorodeoxyglucose positron emission tomography: Case report. Pediatr Hematol Oncol 2001;18:295-298.
8. Schwarzbach MH, Dimitrakopoulou-Strauss A, Willeke F, et al. Clinical value of [18-F] fluorodeoxyglucose positron emission tomography imaging in soft tissue sarcomas. Ann Surg 2000;231:380-386.
9. Hawkins DS, Rajendran JG, Conrad EU III, et al. Evaluation of chemotherapy response in pediatric bone sarcomas by [F-18]-fluorodeoxy-D-glucose positron emission tomography. Cancer 2002;94:3277-3284.
10. Lucas JD, O'Doherty MJ, Wong JC, et al. Evaluation of fluorodeoxyglucose positron emission tomography in the management of soft tissue sarcomas. J Bone Joint Surg Br 1998;80:441-447.
11. Franzius C, Daldrup-Link HE, Sciuk J, et al. FDG-PET for detection of pulmonary metastases from malignant primary bone tumors: Comparison with spiral CT. Ann Oncol 2001;12:479-486.
12. Franzius C, Sciuk J, Daldrup-Link HE, et al. FDG-PET for detection of osseous metastases from malignant primary bone tumors: Comparison with bone scintigraphy. Eur J Nucl Med 2000;27:1305-1311.
13. Daldrup-Link HE, Franzius C, Link TM, et al. Whole-body MR imaging for detection of bone metastases in children and young adults: Comparison with skeletal scintigraphy and FDG PET. Am J Roentgenol 2001;177:229-236.
14. Reboul-Marty J, Quintana E, Mosseri V, et al. Prognostic factors of alveolar rhabdomyosarcoma in childhood. An International Society of Pediatric Oncology study. Cancer 1991;68:493-498.